Navigation Links
Effective ADHD treatment found for children with fragile X syndrome
Date:2/18/2008

Fragile X syndrome (FXS) is the most common hereditary form of mental retardation. Many children with FXS also suffer from attention deficit and/or hyperactivity disorder (ADHD), which complicates social relationships at home and at school. Although stimulant medication such as Ritalin is often successfully used to treat children with ADHD, studies have shown that while it is effective in children with mental retardation, it also causes side effects such as increased irritability, decreased verbalization and social withdrawal.

A previous study showed that L-acetyl carnitine (LAC), a form of the amino acid carnitine, significantly reduced hyperactive behavior in FXS boys with ADHD who were treated with it for one year without causing adverse side effects. The same authors have now conducted a randomized, double-blind, placebo-controlled multicenter study to determine the effectiveness of LAC in a larger group. The study is published in the April 1st, 2008 issue of the American Journal of Medical Genetics Part A, available online via Wiley InterScience at http://www3.interscience.wiley.com/cgi-bin/jhome/33129.

Led by M. Giulia Torrioli and Giovanni Neri of the Universit Cattolica in Rome, the study involved 51 boys between 6 and 12 years old with FXS and ADHD who were treated in one of eight centers in Italy, France and Spain. Each patient followed the treatment for 12 months, which involved 500 milligrams of LAC or a placebo given twice daily. Patients were evaluated by an interdisciplinary team of child neuropsychiatrists and psychologists at the start of the study, after one month, six months and 12 months. The effects of the drug and placebo were evaluated using a set of neuropsychological tests to assess behavior.

Those treated with LAC demonstrated reduced hyperactive behavior and increased attention. No side effects were exhibited, confirming that LAC is a safe
'/>"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
Source:Eurekalert

Page: 1 2

Related biology news :

1. Eltrombopag effective for hepatitis C patients with low blood-platelet counts
2. Safe and effective therapy discovered for patients with protein-losing enteropathy
3. Tamiflu effective for treatment and prevention of influenza in children 1 year and older
4. Gene, stem cell therapy only needs to be 50 percent effective to create a healthy heart
5. Quantitative PET imaging finds early determination of effectiveness of cancer treatment
6. New hope for horse lovers as effective control for killer ragwort is proposed
7. Trial seeks genetic fingerprint for predicting drug effectiveness
8. MIT model could improve some drugs effectiveness
9. New nanoparticle vaccine is more effective but less expensive
10. Socioeconomic position associated with effectiveness of HIV drugs
11. UC health news: molecular pathway may predict chemotherapy effectiveness

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...research suggests that a common oral bacterium may...t by Nichols et al, "Unique Lipids from a Common H...ds Capable of Enhancing Autoimmunity," appears in ...f Pathology . , Multiple sclerosis (MS), a disea...pinal cord, affects nearly 1 in 700 people in the ...
(Date:11/23/2009)...swine vaccine available for the H1N1 virus has bee... virus. The vaccination marks the first time vacci...e pandemic flu., Iowa State University,s Hank Ha...accine this summer and has been shipping preventiv...inois for several weeks., The latest vaccines we...
(Date:11/23/2009)..., 2009 -- A USDOE and USDA study concluded that 50...d cropland pasture could be converted from current... as switchgrass, from which biomass could be harve...viable production of a perennial grass monoculture...removed annually is expected to require nitrogen f...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2How Well Do You Sleep At Night 3F Visit The New Online Aviisha Medical Wellness Institute To Find Out 54874 1How Well Do You Sleep At Night 3F Visit The New Online Aviisha Medical Wellness Institute To Find Out 54874 2How Well Do You Sleep At Night 3F Visit The New Online Aviisha Medical Wellness Institute To Find Out 54874 3Misuse of Pain Medication Draws Heightened Concerns 54870 1Misuse of Pain Medication Draws Heightened Concerns 54870 2Misuse of Pain Medication Draws Heightened Concerns 54870 3Misuse of Pain Medication Draws Heightened Concerns 54870 4Anthem Blue Cross and Blue Shield in Maine Announces Decision to Cover H1N1 Vaccine Administration 54866 1Anthem Blue Cross and Blue Shield in Maine Announces Decision to Cover H1N1 Vaccine Administration 54866 2
...ch sun ?for plants as well as people ?can be harmf... equivalent of "lobster tans," plants have develop... photoprotection, which acts like sunscreen to war...olecules called carotenoids participate in this pr...n, how does this work?" said Iris Visoly-Fisher, a...
...e first time, researchers have developed a way to ...in in enough quantity to learn how it works. , Der...s of a New Zealand cave, the chemical tricks certa... cells untouched. , "In 2000, scientists in Japan...mendous potential as a prototype anticancer agent,...
...g a whole new interface between nanotechnology and...ve used slender silicon nanowires to detect, stimu...d dendrites of live mammalian neurons. , Harvard ... this marriage of nanowires and neurons this week ... artificial synapses between nanoelectronic device...
Other Biology News:How plants avoid feeling the burn 2How plants avoid feeling the burn 3How plants avoid feeling the burn 4New lab technique churns out fungus' potential cancer fighter 2Nanowire arrays can detect signals along individual neurons 2
(Date:11/24/2009)...land,November24/PRNewswire-FirstCall/--deCODE,gene...fallofits,"firstday"motionsbytheU.S.BankruptcyCour...eCODElastweekfiledavoluntarypetitionfor,reliefunde...ankruptcyCourt. , TheordersissuedbytheBankrup...nessduringtheChapter11proceedings.Inparticular,the...
(Date:11/24/2009)...24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,C...rovedthe,investigationalnewdrugapplication(IND)for...formulationtotreatdiabetes.ThisIND,approvalallowsB..., Diabetesisadisordercharacteristicofhighbloodgluc...tenresultinseveremicro-and,macro-vasculardiseases,...
(Date:11/24/2009)...cyendpointhasbeenmetforpatientswithadvanced-stage,...v.24/PRNewswire-FirstCall/-AEternaZentarisInc.(NAS...ceuticalcompanyfocusedonendocrinetherapyandoncolog...dywithitstargetedcytotoxicpeptideconjugate,AEZS-10...tendometrialcancer.Inapersonalizedhealthcareapproa...
(Date:11/24/2009)...24,2009/PRNewswire-FirstCall/--ArenaPharmaceutical...yisscheduledtopresentatthePiperJaffray21stAnnualHe...rnTime(8:30a.m.PacificTime)attheNewYorkPalaceHotel...xecutiveOfficer,isscheduledtoprovideanoverviewofth...ryprograms. ,, Aliveaudiowebcastofthepresentati...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
... Separate Study Also Show Minimal Effect on Heart ...Patients, VIENNA, Austria, Oct. 17 New data show...ng developed by Organon -- is effective,in treatin...isorder. These,results, from two Phase III clinica...ropean College of Neuropsychopharmacology (ECNP) C...
...st time theoretical modeling has provided a glimps... to trap charges, something which may affect the p... revealed in a paper published on the 12th October...London Centre for Nanotechnology and SEMATECH, a c...uest for miniaturization, transistors and all thei...
..., Oct. 16 NxStage Medical,Inc. (Nasdaq: NXTM ), ...ucts, announced plans to release its financial res...r 2, 2007 before the opening of the,financial mark...10:00 a.m. Eastern Time on,November 2, 2007 to dis...listen to the conference call, please dial 800.638...
Other Biology Technology:Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 2Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 3Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 4Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 5Organon's Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder 6Novel gate dielectric materials: perfection is not enough 2NxStage(R) Medical to Report Third Quarter 2007 Financial Results on Friday, November 2nd 2
Bsg I from New England Biolabs
Rabbit Anti-CUGBP2 Monoclonal Antibody, Unconjugated, Clone PADZMD.495 from Invitrogen
GIBCO Geneticin Selective Antibiotic liquid from Invitrogen
LB Broth Base powder (Lennox L Broth Base) from Invitrogen
Biology Products: